These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12404190)

  • 1. Sequential estrogen-progestin replacement therapy in healthy postmenopausal women: effects on cholesterol efflux capacity and key proteins regulating high-density lipoprotein levels.
    Ulloa N; Arteaga E; Bustos P; Durán-Sandoval D; Schulze K; Castro G; Jauhiainen M; Fruchart JC; Calvo C
    Metabolism; 2002 Nov; 51(11):1410-7. PubMed ID: 12404190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein compositional changes with combination hormone therapy (conjugated estrogen and medroxyprogesterone) in African American women.
    Hughes TA; Pace DT; Ke RW; Tolley EA; Qureshi N; Stentz F
    Endocr Pract; 2004; 10(3):179-86. PubMed ID: 15310534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activity of lecithin:cholesterol acyltransferase during short-term oral estrogen progestin replacement therapy in a group of postmenopausal women.
    Ulloa N; Verdugo C; Rios M; Sepúlveda J; Sepúlveda S; Naveas R; Calvo C
    Metabolism; 1998 Mar; 47(3):297-300. PubMed ID: 9500566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive meta-analysis of the effects of oral medroxyprogesterone acetate plus conjugated equine oestrogens on the lipid profile in women: Insights from randomized controlled trials.
    Zhang YL; Xie L; Wu FL; Ding X; Hernández-Wolters B; Găman MA; Kord-Varkaneh H
    Eur J Clin Invest; 2024 Aug; 54(8):e14211. PubMed ID: 38726889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.
    Anderson PW; Cox DA; Sashegyi A; Paul S; Silfen SL; Walsh BW
    Maturitas; 2001 Jul; 39(1):71-7. PubMed ID: 11451623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen.
    Wakatsuki A; Sagara Y
    Maturitas; 1996 Aug; 25(1):35-44. PubMed ID: 8887307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
    Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux.
    von Eckardstein A; Crook D; Elbers J; Ragoobir J; Ezeh B; Helmond F; Miller N; Dieplinger H; Bennink HC; Assmann G
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):49-58. PubMed ID: 12519412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy.
    Yamakawa-Kobayashi K; Somekawa Y; Fujimura M; Tomura S; Arinami T; Hamaguchi H
    Atherosclerosis; 2002 May; 162(1):17-21. PubMed ID: 11947893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
    Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
    Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
    Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Taechakraichana N; Holinka CF; Haines CJ; Subramaniam R; Tian XW; Ausmanas MK
    Climacteric; 2007 Jun; 10(3):225-37. PubMed ID: 17487649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
    Clisham PR; de Ziegler D; Lozano K; Judd HL
    Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.